top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2008; 1:582-591, doi:10.1016/j.jcmg.2008.05.012
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View PowerPoint Slide Set
Right arrow View Related Journal Scan on Cardiosource
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Verma, A.
Right arrow Articles by Solomon, S. D.
PubMed
Right arrow Articles by Verma, A.
Right arrow Articles by Solomon, S. D.
Related Collections
Right arrowRelated Article

Clinical Research

Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction

The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study

Anil Verma, MD*, Alessandra Meris, MD*, Hicham Skali, MD*, Jalal K. Ghali, MD{dagger}, J. Malcolm O. Arnold, MD{ddagger}, Mikhail Bourgoun, MD*, Eric J. Velazquez, MD§, John J.V. McMurray, MD||, Lars Kober, MD, Marc A. Pfeffer, MD, PhD*, Robert M. Califf, MD#, Scott D. Solomon, MD*,*

* Brigham and Women's Hospital, Boston, Massachusetts
{dagger} Wayne State University, Detroit, Michigan
{ddagger} University Hospital, London Health Sciences Centre, London, Ontario, Canada
§ Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
|| Western Infirmary, Glasgow, Scotland
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
# Duke Translational Medicine Institute, Duke University Medical Center, Durham, North Carolina

* Reprint requests and correspondence: Dr. Scott D. Solomon, Associate Professor of Medicine, Director of Noninvasive Cardiology, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115 (Email: ssolomon{at}rics.bwh.harvard.edu).

Objectives: This study sought to understand prognostic implications of increased baseline left ventricular (LV) mass and geometric patterns in a high risk acute myocardial infarction.

Background: The LV hypertrophy and alterations in LV geometry are associated with an increased risk of adverse cardiovascular events.

Methods: Quantitative echocardiographic analyses were performed at baseline in 603 patients from the VALIANT (VALsartan In Acute myocardial iNfarcTion) echocardiographic study. The left ventricular mass index (LVMi) and relative wall thickness (RWT) were calculated. Patients were classified into 4 mutually exclusive groups based on RWT and LVMi as follows: normal geometry (normal LVMi and normal RWT), concentric remodeling (normal LVMi and increased RWT), eccentric hypertrophy (increased LVMi and normal RWT), and concentric hypertrophy (increased LVMi and increased RWT). Cox proportional hazards models were used to evaluate the relationships among LVMi, RWT, LV geometry, and clinical outcomes.

Results: Mean LVMi and RWT were 98.8 ± 28.4 g/m2 and 0.38 ± 0.08. The risk of death or the composite end point of death from cardiovascular causes, reinfarction, heart failure, stroke, or resuscitation after cardiac arrest was lowest for patients with normal geometry, and increased with concentric remodeling (hazard ratio [HR]: 3.0; 95% confidence interval [CI]: 1.9 to 4.9), eccentric hypertrophy (HR: 3.1; 95% CI: 1.9 to 4.8), and concentric hypertrophy (HR: 5.4; 95% CI: 3.4 to 8.5), after adjusting for baseline covariates. Also, baseline LVMi and RWT were associated with increased mortality and nonfatal cardiovascular outcomes (HR: 1.22 per 10 g/m2 increase in LVMi; 95% CI: 1.20 to 1.30; p < 0.001) (HR: 1.60 per 0.1-U increase in RWT; 95% CI: 1.30 to 1.90; p < 0.001). Increased risk associated with RWT was independent of LVMi.

Conclusions: Increased baseline LV mass and abnormal LV geometry portend an increased risk for morbidity and mortality following high-risk myocardial infarction. Concentric LV hypertrophy carries the greatest risk of adverse cardiovascular events including death. Higher RWT was associated with an increased risk of cardiovascular complications after high-risk myocardial infarction.

Key Words: left ventricular mass • left ventricular geometry • myocardial infarction • relative wall thickness • echocardiography • prognosis

Abbreviations and Acronyms
  EF = ejection fraction
  LA = left atrial
  LV = left ventricular
  LVMi = left ventricular mass index
  MI = myocardial infarction
  RV = right ventricular
  RWT = relative wall thickness


Related Article

Patterns of Ventricular Remodeling After Myocardial Infarction: Clues Toward Linkage Between Mechanism and Morbidity
Marvin A. Konstam
J. Am. Coll. Cardiol. Img. 2008 1: 592-594. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
M. A. Konstam
Patterns of Ventricular Remodeling After Myocardial Infarction: Clues Toward Linkage Between Mechanism and Morbidity
J. Am. Coll. Cardiol. Img., September 1, 2008; 1(5): 592 - 594.
[Full Text] [PDF]



 
   
 
home link current link search link archive link topics link cardiology careers link